SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53

References

• Zhu H, Wu K, Yan W, Hu L, Yuan J, Dong Y, Li Y, Jing K, Yang Y, Guo M. Epigenetic silencing of DACH1 induces loss of transforming growth factor-beta1 antiproliferative response in human hepatocellular carcinoma. Hepatology. 2013;58(6):2012–22. doi.org/10.1002/hep.26587 PMID:23787902.
   PubMed Web of Science ®Google Scholar
• Suen AA, Jefferson WN, Wood CE, Padilla-Banks E, Bae-Jump VL, Williams CJ. SIX1 oncoprotein as a biomarker in a model of hormonal carcinogenesis and in human endometrial cancer. Mol Cancer Res. 2016;14(9):849–58. doi.org/10.1158/1541-7786.MCR-16-0084 PMID:27259717.
   PubMed Web of Science ®Google Scholar
• Xu H, Zhang Y, Pena MM, Pirisi L, Creek KE. Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages. Carcinogenesis. 2017;38(3):281–92. doi.org/10.1093/carcin/bgw121 PMID:28199476.
   PubMed Web of Science ®Google Scholar
• Chao L, Liu J, Zhao D. Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma. Oncol Lett. 2017;13(5):2891–96. doi.org/10.3892/ol.2017.5803 PMID:28521394.
   PubMed Web of Science ®Google Scholar
• Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, Wang J, Li Z, Addya S, Sorensen PH, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74(3):829–39. doi.org/10.1158/0008-5472.CAN-13-2466 PMID:24335958.
   PubMed Web of Science ®Google Scholar
• Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Res. 2013;73(11):3262–74. doi.org/10.1158/0008-5472.CAN-12-3191 PMID:23492369.
   PubMed Web of Science ®Google Scholar
• Lee JW, Kim HS, Kim S, Hwang J, Kim YH, Lim GY, Sohn WJ, Yoon SR, Kim JY, Park TS, et al. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1. Biochem Biophys Res Commun. 2012;420(1):91–5. doi.org/10.1016/j.bbrc.2012.02.120 PMID:22405764.
   PubMed Web of Science ®Google Scholar
• Martik ML, McClay DR. Deployment of a retinal determination gene network drives directed cell migration in the sea urchin embryo. Elife. 2015;4:e08827. doi.org/10.7554/eLife.08827 PMID:26402456.
   PubMed Web of Science ®Google Scholar
• Liu Y, Han N, Zhou S, Zhou R, Yuan X, Xu H, Zhang C, Yin T, Wu K. The DACH/EYA/SIX gene network and its role in tumor initiation and progression. Int J Cancer. 2016;138(5):1067–75. doi.org/10.1002/ijc.29560 PMID:26096807.
   PubMed Web of Science ®Google Scholar
• Miller SJ, Lan ZD, Hardiman A, Wu J, Kordich JJ, Patmore DM, Hegde RS, Cripe TP, Cancelas JA, Collins MH, et al. Inhibition of eyes absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene. 2010;29(3):368–79. doi.org/10.1038/onc.2009.360 PMID:19901965.
   PubMed Web of Science ®Google Scholar
• Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 2002;71(16):1879–92. PMID:12175703
   PubMed Web of Science ®Google Scholar
• Meng X, Franklin DA, Dong J, Zhang Y. MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res. 2014;74(24):7161–7. doi.org/10.1158/0008-5472.CAN-14-1446 PMID:25477334.
   PubMed Web of Science ®Google Scholar
• Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet. 2004;36(2):147–50. doi.org/10.1038/ng1293 PMID:14730303.
   PubMed Web of Science ®Google Scholar
• Zeng J, Shi R, Cai CX, Liu XR, Song YB, Wei M, Ma WL. Increased expression of Six1 correlates with progression and prognosis of prostate cancer. Cancer Cell Int. 2015;15:63. doi.org/10.1186/s12935-015-0215-z PMID:26161040.
   PubMed Web of Science ®Google Scholar
• Lerbs T, Bisht S, Scholch S, Pecqueux M, Kristiansen G, Schneider M, Hofmann BT, Welsch T, Reissfelder C, Rahbari NN, et al. Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer. BMC Cancer. 2017;17(1):249. doi.org/10.1186/s12885-017-3225-5 PMID:28388884.
   PubMedGoogle Scholar
• Tian T, Li A, Lu H, Luo R, Zhang M, Li Z. Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor. Am J Cancer Res. 2015;5(5):1823–30. PMID:26175950
   PubMed Web of Science ®Google Scholar
• Chu Q, Han N, Yuan X, Nie X, Wu H, Chen Y, Guo M, Yu S, Wu K. DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells. J Hematol Oncol. 2014;7:73. doi.org/10.1186/s13045-014-0073-5 PMID:25322986.
   PubMed Web of Science ®Google Scholar
• Han N, Yuan X, Wu H, Xu H, Chu Q, Guo M, Yu S, Chen Y, Wu K. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling. Oncotarget. 2015;6(8):5877–88. doi.org/10.18632/oncotarget.3463 PMID:25788272.
   PubMedGoogle Scholar
• Wu L, Herman JG, Brock MV, Wu K, Mao G, Yan W, Nie Y, Liang H, Zhan Q, Li W, et al. Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-beta signaling. PLoS One. 2014;9(4):e95509. doi.org/10.1371/journal.pone.0095509 PMID:24743895.
   PubMed Web of Science ®Google Scholar
• Huang Q, Li J, Xing J, Li W, Li H, Ke X, Zhang J, Ren T, Shang Y, Yang H, et al. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway. J Hepatol. 2014;61(4):859–66. doi.org/10.1016/j.jhep.2014.04.035 PMID:24801417.
   PubMed Web of Science ®Google Scholar
• Ren ZJ, Nong XY, Lv YR, Sun HH, An PP, Wang F, Li X, Liu M, Tang H. Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth. Cell Death Dis. 2014;5:e1387. doi.org/10.1038/cddis.2014.327 PMID:25144722.
   PubMed Web of Science ®Google Scholar